Evolent Health, Inc.
EVH
$4.13
-$0.03-0.72%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.89B | 1.88B | 2.05B | 2.20B | 2.40B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.89B | 1.88B | 2.05B | 2.20B | 2.40B |
| Cost of Revenue | 1.51B | 1.48B | 1.68B | 1.84B | 2.03B |
| Gross Profit | 381.19M | 399.88M | 378.34M | 359.26M | 365.72M |
| SG&A Expenses | 284.13M | 288.47M | 273.60M | 261.40M | 254.54M |
| Depreciation & Amortization | 113.35M | 115.85M | 78.51M | 84.60M | 91.33M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.91B | 1.88B | 2.03B | 2.18B | 2.38B |
| Operating Income | -16.29M | -4.44M | 26.24M | 13.26M | 19.86M |
| Income Before Tax | -497.21M | -534.64M | -127.75M | -131.55M | -109.47M |
| Income Tax Expenses | -686.00K | -126.00K | 430.00K | -1.10M | -508.00K |
| Earnings from Continuing Operations | -496.52 | -534.51 | -128.18 | -130.45 | -108.96 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -496.52M | -534.51M | -128.18M | -130.45M | -108.96M |
| EBIT | -16.29M | -4.44M | 26.24M | 13.26M | 19.86M |
| EBITDA | 74.36M | 88.22M | 80.95M | 73.36M | 85.58M |
| EPS Basic | -4.76 | -5.15 | -1.57 | -1.61 | -1.22 |
| Normalized Basic EPS | -0.42 | -0.60 | -0.36 | -0.39 | -0.33 |
| EPS Diluted | -4.76 | -5.15 | -1.57 | -1.61 | -1.22 |
| Normalized Diluted EPS | -0.42 | -0.60 | -0.36 | -0.39 | -0.33 |
| Average Basic Shares Outstanding | 453.47M | 456.88M | 460.30M | 461.09M | 459.90M |
| Average Diluted Shares Outstanding | 453.47M | 456.88M | 460.30M | 461.09M | 459.90M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -1.32% | -2.08% | -12.43% | -14.67% | -17.97% |